Orsted A/S (ORSTED)
Copenhagen Exchange · Denmark · prices in DKK · close of 22 Oct 2026
Key indicators
| Last close | DKK 129.85 |
|---|---|
| 52-week range | 111.00 – 172.20 |
| Return, 1 month / 3 months | −8.7% / −15.2% |
| Return, 1 year / 3 years | +10.1% / −28.2% |
| Trend | Below its 200-day average |
| RSI (14) | 47 |
| Volatility (1 year) | 35.7% |
| Worst drawdown (1 year) | -26.7% |
| Average daily value traded | 224.99M DKK |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Orsted is a Danish energy company based in Denmark that develops and operates offshore wind farms, along with onshore wind and solar projects. It produces and supplies electricity to households, businesses and utilities, and it also runs bioenergy plants that generate heat and power. The company works with partners and governments on building renewable energy installations in European and other markets, and it manages the power it generates through long-term supply agreements with corporate and industrial customers.
Orsted A/S trades under the code ORSTED on the Copenhagen Exchange in Denmark, with its price quoted in Danish kroner (DKK). Our dividend records, which start in 2019, show payments in 5 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Orsted A/S (ORSTED) trades on the Copenhagen Exchange in Denmark. It last closed at DKK 129.85 on 22 October 2026.
Its price-based Market X-Ray is 44 out of 100 (a weak price profile), ranking 106 of 164 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 10.1% and over the last three months it fell 15.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Copenhagen Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 23 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -11.5% | ||
| From 52-week high | -23.8% | ||
| Momentum | 34 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -15.2% | ||
| 6-month return | -20.4% | ||
| 12-month return, skipping the last month | 20.6% | ||
| Stability (higher is calmer) | 44 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 35.7% | ||
| Worst drawdown, 1 year (smaller is calmer) | -26.7% | ||
| Liquidity | 96 · Strong | Trades actively. | |
| Average daily value traded | 224.99M DKK | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 2 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | +3.4% |
|---|---|
| 1 month | −8.7% |
| 3 months | −15.2% |
| 6 months | −20.4% |
| 1 year | +10.1% |
| 3 years | −28.2% |
| 5 years | −73.3% |
Signals
| 50-day / 200-day average | 134.67 / 146.80 |
|---|---|
| Golden / death cross (60 days) | Death, 42 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 3.85 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 8 Mar 2023 | DKK 13.5000 |
| 11 Apr 2022 | DKK 12.5000 |
| 2 Mar 2021 | DKK 11.5000 |
| 3 Mar 2020 | DKK 10.5000 |
| 6 Mar 2019 | DKK 9.7500 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Copenhagen Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.